BISMUTH SUBNITRATE

BISMUTH SUBNITRATE was reported 621 times

BISMUTH SUBNITRATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTACID THERAPY 48 0.3692
1 SLEEP DISORDER THERAPY 58 0.2929
2 CONGENITAL HIATUS HERNIA 51 0.2237
3 MALIGNANT MELANOMA STAGE 0 42 0.2010
4 ANALGESIC THERAPY 60 0.1869
5 DRUG THERAPY 59 0.1740
6 APPENDICOLITH 67 0.1731
7 ANTICOAGULANT THERAPY 48 0.1690
8 BACTEROIDES INFECTION 24 0.0920
9 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 45 0.0485
10 HYPERPHOSPHATAEMIA 77 0.0358
11 BLOOD PHOSPHORUS INCREASED 60 0.0220
12 TOTAL LUNG CAPACITY DECREASED 27 0.0169
13 PLEURITIC PAIN 40 0.0145
14 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 73 0.0144
15 RESPIRATORY SYMPTOM 37 0.0130
16 MYASTHENIA GRAVIS 93 0.0115
17 HYPOPHOSPHATAEMIA 84 0.0114
18 IRON DEFICIENCY 49 0.0109
19 BLOOD URIC ACID INCREASED 61 0.0106
20 LUNG OPACITY 25 0.0095
21 AORTIC STENOSIS 33 0.0095
22 BENIGN PROSTATIC HYPERPLASIA 44 0.0085
23 BREATH SOUNDS ABNORMAL 39 0.0079
24 TROPONIN INCREASED 58 0.0076
25 APPENDICITIS 67 0.0072
26 BLOOD CALCIUM INCREASED 55 0.0063
27 VENTRICULAR FIBRILLATION 67 0.0060
28 HYPERLIPIDAEMIA 61 0.0051
29 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 83 0.0048
30 CARDIOGENIC SHOCK 66 0.0046
31 BACTERIAL INFECTION 80 0.0043
32 ULCER 66 0.0041
33 HYPERCHOLESTEROLAEMIA 39 0.0040
34 ASPIRATION 44 0.0040
35 BLOOD TEST ABNORMAL 55 0.0039
36 FULL BLOOD COUNT ABNORMAL 39 0.0037
37 GOUT 65 0.0036
38 MICTURITION URGENCY 40 0.0035
39 NEURALGIA 85 0.0035
40 END STAGE RENAL DISEASE 63 0.0035
41 MULTIPLE ORGAN DYSFUNCTION SYNDROME 95 0.0034
42 ASCITES 68 0.0023
43 POSTRENAL FAILURE 1 0.0023
44 JOINT INJURY 42 0.0020
45 TRANSAMINASES INCREASED 40 0.0018
46 XEROPHTHALMIA 1 0.0017
47 HYPONATRAEMIA 95 0.0017
48 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 86 0.0016
49 RALES 9 0.0015
50 BRONCHIECTASIS 10 0.0015
51 CARDIOVASCULAR DISORDER 37 0.0015
52 CORONARY ARTERY DISEASE 43 0.0014
53 BLOOD CHOLESTEROL INCREASED 60 0.0013
54 LOWER RESPIRATORY TRACT INFECTION 58 0.0013
55 MEAN PLATELET VOLUME DECREASED 1 0.0012
56 IRON DEFICIENCY ANAEMIA 11 0.0012
57 TRANSIENT ISCHAEMIC ATTACK 40 0.0012
58 INJECTION SITE COLDNESS 1 0.0012
59 SLEEP DISORDER 82 0.0012
60 DIABETES MELLITUS 86 0.0011
61 THROMBOSIS 83 0.0010
62 INTENTIONAL PRODUCT MISUSE 84 0.0010
63 SPUTUM DISCOLOURED 9 0.0009
64 UPPER RESPIRATORY TRACT INFECTION 42 0.0009
65 SWELLING 85 0.0009
66 DRUG INTOLERANCE 86 0.0009
67 LIVER FUNCTION TEST INCREASED 19 0.0009
68 PULMONARY EMBOLISM 83 0.0009
69 LIVER DISORDER 38 0.0009
70 BLOOD CREATININE INCREASED 55 0.0008
71 SEPSIS 93 0.0008
72 GENERAL PHYSICAL HEALTH DETERIORATION 95 0.0008
73 OTITIS EXTERNA 1 0.0008
74 OBSTRUCTIVE AIRWAYS DISORDER 9 0.0008
75 MALIGNANT MELANOMA IN SITU 1 0.0008
76 DRY MOUTH 64 0.0008
77 RHONCHI 1 0.0007
78 LUNG DISORDER 35 0.0007
79 GLUTEN SENSITIVITY 1 0.0007
80 ABDOMINAL DISTENSION 71 0.0007
81 MUSCULOSKELETAL STIFFNESS 58 0.0007
82 PULMONARY MASS 9 0.0006
83 HAEMOPTYSIS 15 0.0005
84 PLEURAL EFFUSION 29 0.0005
85 PULMONARY FIBROSIS 9 0.0005
86 SOMNOLENCE 93 0.0005
87 OEDEMA PERIPHERAL 55 0.0005
88 GASTROINTESTINAL DISORDER 40 0.0004
89 SUSPECTED OFF LABEL USE 2 0.0004
90 HAEMANGIOMA 1 0.0004
91 ANAEMIA 82 0.0004
92 BILIRUBIN CONJUGATED INCREASED 1 0.0004
93 GASTROINTESTINAL OBSTRUCTION 1 0.0004
94 ASPARTATE AMINOTRANSFERASE INCREASED 22 0.0004
95 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
96 ASTHMA 44 0.0004
97 RHINALGIA 1 0.0004
98 CONSTIPATION 69 0.0003
99 CONDITION AGGRAVATED 94 0.0003
100 HYPERTENSION 63 0.0003
101 ABDOMINAL PAIN 67 0.0003
102 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
103 VULVOVAGINAL MYCOTIC INFECTION 1 0.0003
104 OESOPHAGEAL CANDIDIASIS 1 0.0003
105 PRODUCT USE IN UNAPPROVED INDICATION 60 0.0002
106 TREMOR 40 0.0002
107 HYPOXIA 8 0.0002
108 BLOOD CREATINE INCREASED 1 0.0002
109 YELLOW SKIN 1 0.0002
110 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
111 CARDIAC FAILURE ACUTE 1 0.0001
112 VOMITING 69 0.0001
113 LYMPHOEDEMA 1 0.0001
114 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 26 0.0001
115 PRODUCT DOSE OMISSION ISSUE 42 0.0001
116 WHEEZING 8 0.0001
117 HYDRONEPHROSIS 1 0.0001
118 PAROSMIA 1 0.0001
119 GASTROOESOPHAGEAL REFLUX DISEASE 10 0.0001
120 ASTHENIA 44 0.0001
121 PYREXIA 40 0.0001
122 OFF LABEL USE 94 0.0001
123 BODY TEMPERATURE DECREASED 1 0.0001
124 TOXIC SKIN ERUPTION 1 0.0001
125 DYSPNOEA 55 0.0001
126 INJECTION SITE DISCOMFORT 1 0.0001
127 SUDDEN DEATH 1 0.0001
128 PNEUMONIA 29 0.0001
129 EYE INFECTION 1 0.0001
130 NAUSEA 70 0.0001
131 ACCIDENT 1 0.0001
132 MUCOSAL INFLAMMATION 2 0.0001
133 DEVICE OCCLUSION 1 0.0001
134 SEASONAL ALLERGY 1 0.0001
135 HEADACHE 41 0.0001
136 LUNG INFECTION 1 0.0001
137 PAIN 39 0.0001
138 METASTASES TO BONE 1 0.0001
139 PERICARDITIS 1 0.0001
140 TOOTHACHE 1 0.0001
141 HAEMORRHOIDS 1 0.0001
142 SKIN FISSURES 1 0.0001
143 FATIGUE 38 0.0000
144 INJECTION SITE WARMTH 1 0.0000
145 DRUG INEFFECTIVE 63 0.0000
146 DERMATITIS 1 0.0000
147 GLOSSODYNIA 1 0.0000
148 ABDOMINAL PAIN UPPER 9 0.0000
149 PERICARDIAL EFFUSION 1 0.0000
150 LIVER INJURY 1 0.0000
151 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
152 DEATH 34 0.0000
153 ECZEMA 2 0.0000
154 GASTRITIS 1 0.0000
155 EAR INFECTION 1 0.0000
156 BLOOD BILIRUBIN INCREASED 1 0.0000
157 DIVERTICULITIS 1 0.0000
158 FEELING COLD 1 0.0000
159 DEMENTIA 1 0.0000
160 LIMB DISCOMFORT 1 0.0000
161 COUGH 9 0.0000
162 SWOLLEN TONGUE 1 0.0000
163 EYE DISORDER 1 0.0000
164 VIRAL INFECTION 1 0.0000
165 HEPATIC FUNCTION ABNORMAL 1 0.0000
166 CARDIO-RESPIRATORY ARREST 1 0.0000
167 NEUROPATHY PERIPHERAL 2 0.0000
168 PRODUCTIVE COUGH 1 0.0000
169 CONTUSION 2 0.0000
170 INTERSTITIAL LUNG DISEASE 1 0.0000
171 PANCREATITIS 1 0.0000
172 PLATELET COUNT DECREASED 2 0.0000
173 HAEMATOCHEZIA 1 0.0000
174 MEDICATION ERROR 1 0.0000
175 DYSPHONIA 1 0.0000
176 NASAL CONGESTION 1 0.0000
177 RHINORRHOEA 1 0.0000
178 BRONCHITIS 1 0.0000
179 DYSGEUSIA 1 0.0000
180 EPISTAXIS 1 0.0000
181 DRUG ABUSE 1 0.0000
182 SKIN EXFOLIATION 1 0.0000
183 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
184 DIARRHOEA 7 0.0000
185 OROPHARYNGEAL PAIN 1 0.0000
186 SINUSITIS 1 0.0000
187 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
188 INFLUENZA 1 0.0000
189 PAIN IN EXTREMITY 2 0.0000
190 HYPOAESTHESIA 1 0.0000
191 ABDOMINAL DISCOMFORT 1 0.0000
192 NASOPHARYNGITIS 1 0.0000
193 HYPERSENSITIVITY 1 0.0000
194 GAIT DISTURBANCE 1 0.0000
195 DECREASED APPETITE 1 0.0000
196 WEIGHT DECREASED 1 0.0000
197 INJECTION SITE PAIN 1 0.0000
198 FALL 1 0.0000
199 MALAISE 1 0.0000
200 DIZZINESS 1 0.0000